This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Vifor Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of G2AB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders81,7270.113%
Institutions8,510,53611.7%
Public Companies63,849,04588.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 111.12% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
98.4%
CSL Limited
63,849,045€10.0b0%no data
3.85%
Credit Suisse Asset Management (Switzerland)
2,495,385€390.5m0%0.39%
2.36%
Swisscanto Asset Management AG
1,533,324€240.0m0%4.83%
2.32%
Vontobel Fonds Services AG
1,502,395€235.1m0%62.31%
2.25%
Norges Bank Investment Management
1,463,154€229.0m0%0.03%
0.6%
Sarasin & Partners LLP
390,000€61.0m0%0.46%
0.32%
The Vanguard Group, Inc.
206,997€32.4m0%no data
0.14%
BCV Asset Management
89,577€14.0m0%0.4%
0.13%
Pictet Asset Management Limited
84,006€13.1m0%0.01%
0.087%
Bellevue Asset Management AG
56,299€8.8m0%0.1%
0.071%
Bank Von Graffenried AG, Asset Management Arm
45,861€7.2m0%2.36%
0.068%
1741 Fund Solutions
44,168€6.9m0%4.32%
0.054%
Legal & General Investment Management Limited
34,991€5.5m-24.8%no data
0.054%
Amundi Asset Management
34,791€5.4m-94.6%no data
0.053%
Berner Kantonalbank, Asset Management Arm
34,562€5.4m0%1.9%
0.052%
Christoph Springer
33,889€5.3m0%no data
0.046%
Aargauische Kantonalbank, Asset Management Arm
30,060€4.7m0%0.88%
0.044%
Dimensional Fund Advisors LP
28,828€4.5m-92.9%no data
0.04%
HSBC Global Asset Management (UK) Limited
25,899€4.1m-2.39%no data
0.039%
AP Fonden 2
25,073€3.9m0%0.03%
0.037%
Assenagon Asset Management S.A.
24,214€3.8m0%0.01%
0.032%
Ignis Investment Services Limited
20,871€3.3m0%0.01%
0.032%
AP Fonden 4
20,668€3.2m0%0.02%
0.031%
SPP Fonder AB
20,064€3.1m0%0.02%
0.021%
BlackRock, Inc.
13,512€2.1m-99.5%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2022/12/26 13:43
End of Day Share Price 2022/12/23 00:00
Earnings2021/12/31
Annual Earnings2021/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vifor Pharma AG is covered by 22 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Armelle MoulinAlphaValue
Volker BosseBaader Helvea Equity Research
Jean-Philippe BertschyBank Vontobel AG